EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 0.6250
+0.0250 (4.17%)
May 8, 2026, 3:55 PM AEST
EZZ Life Science Holdings Market Cap
EZZ Life Science Holdings has a market cap or net worth of 29.42 million as of May 8, 2026. Its market cap has decreased by -58.43% in one year.
Market Cap
29.42M
Enterprise Value
14.86M
Revenue
61.40M
Ranking
n/a
PE Ratio
10.19
Stock Price
0.63
Market Cap Chart
Since March 3, 2021, EZZ Life Science Holdings's market cap has decreased from 48.72M to 29.42M, a decrease of -39.62%. That is a compound annual growth rate of -9.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 29.42M | -55.65% |
| Dec 31, 2025 | 66.33M | -54.20% |
| Dec 31, 2024 | 144.82M | 421.72% |
| Dec 29, 2023 | 27.76M | 73.11% |
| Dec 30, 2022 | 16.04M | -26.47% |
| Dec 31, 2021 | 21.81M | -55.24% |
| Mar 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prescient Therapeutics | 55.73M |
| Neurizon Therapeutics | 55.66M |
| Imugene | 46.38M |
| Avecho Biotechnology | 44.08M |
| NeuroScientific Biopharmaceuticals | 33.26M |
| Proteomics International Laboratories | 30.56M |
| Algorae Pharmaceuticals | 28.32M |
| Noxopharm | 22.12M |